RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+1.97%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$327M
AUM Growth
+$327M
(-3.1%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
25.93%
Holding
105
New
8
Increased
44
Reduced
37
Closed
6
Top Buys
| 1 |
Universal Health Services
UHS
|
$7.18M |
| 2 |
Medtronic
MDT
|
$6.87M |
| 3 |
AbbVie
ABBV
|
$6.41M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$4.4M |
| 5 |
Alkermes
ALKS
|
$4.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$11.5M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$8.22M |
| 3 |
CELG
Celgene Corp
CELG
|
$7.28M |
| 4 |
Biogen
BIIB
|
$6.95M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$6.58M |
Sector Composition
| 1 | Healthcare | 82.32% |
| 2 | Financials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Johnson & Johnson
JNJ
$429B
| – | – |
0
| – | – |
|
102
Intuitive Surgical
ISRG
$158B
| – | – |
-2,500
| Closed | -$1.03M |
|
103
Haemonetics
HAE
$2.57B
| – | – |
-10,047
| Closed | -$354K |
|